article thumbnail

Q&A: One scientist’s bold vision to make on-demand treatments routine for life-threatening rare genetic diseases

Broad Institute

While doctors are cautious about using the word "cure" so early, it is a triumph for K.J.'s Doctors took donor T cells and performed three precise base edits on them, engineering them to attack leukemia cells while leaving healthy cells alone. s blood ammonia levels have dropped to the high end of normal for an infant.

Treatment 133
article thumbnail

Spirulina’s role in shaping the future of preventative biologics

Drug Target Review

Finrow highlights the economic challenges within the sector, particularly the reluctance of doctors to use new antibiotics when cheaper generic options are available. “Doctors face incentives to prioritise generic antibiotic use first because they are cheaper, leaving novel antibiotics as a last resort.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Leveraging agonist antibodies to address immunological diseases

Drug Target Review

Agonist antibodies of immune checkpoint regulators These represent a groundbreaking class of immunotherapeutic agents that mimic the natural function of endogenous ligands by binding to specific cell-surface receptors. This approach augments the strength of achieving immune homeostasis.

Disease 52
article thumbnail

Merck to buy Verona and its lung drug in $10B deal

BioPharma Drive: Drug Pricing

Tsai said he doesn’t expect any risks to the deal from antitrust regulators at the Federal Trade Commission. Most Popular Deep Dive Protein degraders: chasing undruggable targets Cargo agrees to Concentra buyout after trial setback, layoffs Apogee touts positive data for atopic dermatitis drug Medical groups, pregnant doctor sue RFK Jr.

article thumbnail

Evidence v. Belief: What a Kennedy Appointment Could Mean to FDA and Public Health

FDA Law Blog: Biosimilars

Although not altogether surprising, the formality of an official announcement still came as a shock to many of us who work in areas regulated by HHS, as well as to many others in the public health arena. In the meantime, this belief was followed for centuries by doctors, to the detriment of countless patients.

FDA 116
article thumbnail

Perficient Receives Corporate Champion Award from Cystic Fibrosis Foundation’s Gateway Chapter

Perficient: Drug Development

Through scientific research and clinical trials , scientists can understand more about the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein, which maintains a balance between the bodys salt and water distribution. Cystic fibrosis also has a large impact on the families and loved ones of those who have the disease.

Disease 52
article thumbnail

#ScienceSaturday: October 21, 2023

KIF1A

But what regulates the delivery of materials at these early stages? In this week’s article, researchers investigated KIF1A’s role in the delivery of synaptic building blocks, and its regulation by the lipid (fat molecule) PI(3,5)P2. From Gabrych et al.